These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32049380)

  • 1. Investigating the associations of mucosal P2Y6 receptor expression and urinary ATP and ADP concentrations, with symptoms of overactive bladder.
    Firouzmand S; Ajori L; Towse J; Allameh F; Najafi S; Javed S; John B; Langley SEM; Fry CH; Young JS
    Neurourol Urodyn; 2020 Mar; 39(3):926-934. PubMed ID: 32049380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study to investigate the associations of urinary concentrations of NO, ATP and derivatives with overactive bladder symptom severity.
    Firouzmand S; Young JS
    Exp Physiol; 2020 Jun; 105(6):932-939. PubMed ID: 32170890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of P2Y6 Receptors Facilitates Nonneuronal Adenosine Triphosphate and Acetylcholine Release from Urothelium with the Lamina Propria of Men with Bladder Outlet Obstruction.
    Silva I; Ferreirinha F; Magalhães-Cardoso MT; Silva-Ramos M; Correia-de-Sá P
    J Urol; 2015 Oct; 194(4):1146-54. PubMed ID: 26004864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered urothelial ATP signaling in a major subset of human overactive bladder patients with pyuria.
    Contreras-Sanz A; Krska L; Balachandran AA; Curtiss NL; Khasriya R; Kelley S; Strutt M; Gill HS; Taylor KM; Mansfield KJ; Wu C; Peppiatt-Wildman CM; Malone-Lee J; Duckett J; Wildman SS
    Am J Physiol Renal Physiol; 2016 Oct; 311(4):F805-F816. PubMed ID: 27358056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of P2Y6 receptors increases the voiding frequency in anaesthetized rats by releasing ATP from the bladder urothelium.
    Carneiro I; Timóteo MA; Silva I; Vieira C; Baldaia C; Ferreirinha F; Silva-Ramos M; Correia-de-Sá P
    Br J Pharmacol; 2014 Jul; 171(14):3404-19. PubMed ID: 24697602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of brainderived neurotrophic factor in urine of patients with benign prostatic hyperplasia complicated overactive bladder symptoms].
    Hu H; Xu KX; Zhang XP; Fang ZW; Chen JW; Huo F; Wang D; Wang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 46(4):519-23. PubMed ID: 25131461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome.
    Silva-Ramos M; Silva I; Oliveira O; Ferreira S; Reis MJ; Oliveira JC; Correia-de-Sá P
    PLoS One; 2013; 8(5):e64696. PubMed ID: 23741373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls.
    Cheng Y; Mansfield KJ; Allen W; Millard RJ; Burcher E; Moore KH
    Neurourol Urodyn; 2013 Sep; 32(7):969-73. PubMed ID: 23129360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between lower urinary tract symptoms and urinary ATP in patients with benign prostatic hyperplasia or overactive bladder.
    Sugaya K; Nishijima S; Kadekawa K; Miyazato M; Mukouyama H
    Biomed Res; 2009 Oct; 30(5):287-94. PubMed ID: 19887725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP released via pannexin-1 hemichannels mediates bladder overactivity triggered by urothelial P2Y6 receptors.
    Timóteo MA; Carneiro I; Silva I; Noronha-Matos JB; Ferreirinha F; Silva-Ramos M; Correia-de-Sá P
    Biochem Pharmacol; 2014 Jan; 87(2):371-9. PubMed ID: 24269631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New participant stratification and combination of urinary biomarkers and confounders could improve diagnostic accuracy for overactive bladder.
    Firouzmand S; Ajori L; Young JS
    Sci Rep; 2020 Feb; 10(1):3085. PubMed ID: 32080289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
    Lai H; Gardner V; Vetter J; Andriole GL
    BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic Analysis of Urothelium of Rats with Detrusor Overactivity Induced by Bladder Outlet Obstruction.
    Park EC; Lim JS; Kim SI; Lee SY; Tak YK; Choi CW; Yun S; Park J; Lee M; Chung HK; Kim KS; Na YG; Shin JH; Kim GH
    Mol Cell Proteomics; 2018 May; 17(5):948-960. PubMed ID: 29414759
    [No Abstract]   [Full Text] [Related]  

  • 14. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment.
    Peyronnet B; Mironska E; Chapple C; Cardozo L; Oelke M; Dmochowski R; Amarenco G; Gamé X; Kirby R; Van Der Aa F; Cornu JN
    Eur Urol; 2019 Jun; 75(6):988-1000. PubMed ID: 30922690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-3 adrenergic receptors could be significant factors for overactive bladder-related symptoms.
    Yamamichi F; Shigemura K; Behnsawy HM; Yamashita M; Shirakawa T; Fujisawa M
    Int J Clin Exp Pathol; 2015; 8(9):11863-70. PubMed ID: 26617941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented bladder urothelial polyamine signaling and block of BK channel in the pathophysiology of overactive bladder syndrome.
    Li M; Sun Y; Simard JM; Wang JY; Chai TC
    Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1445-51. PubMed ID: 19812367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence.
    Kuo HC; Liu HT; Chancellor MB
    Neurourol Urodyn; 2010 Mar; 29(3):482-7. PubMed ID: 19367641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of non-neurogenic overactive bladder and urinary incontinence over 5 years in community-dwelling older men: The concord health and aging in men project.
    Noguchi N; Chan L; Cumming RG; Blyth FM; Handelsman DJ; Waite LM; Le Couteur DG; Naganathan V
    Neurourol Urodyn; 2017 Feb; 36(2):443-448. PubMed ID: 26756291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy.
    Liu HT; Lin H; Kuo HC
    Neurourol Urodyn; 2011 Nov; 30(8):1525-9. PubMed ID: 21826717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: pathophysiology and pharmacotherapy of overactive bladder.
    Yoshida M; Masunaga K; Nagata T; Yono M; Homma Y
    J Pharmacol Sci; 2010; 112(2):128-34. PubMed ID: 20134115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.